Setria® Glutathione

Kyowa Hakko will host a special session titled “Setria® Performance Blend - A New Dietary Approach to Enhance and Sustain Nitric Oxide Availability” to introduce and discuss the benefits of its latest patent-pending blend targeting athletes and sports enthusiasts at Vitafoods™ Europe on May16th in Geneva, Switzerland.

Karen Todd, Registered Dietitian and Sr. Director of Global Marketing for Kyowa Hakko USA, will review scientific studies of Setria® Glutathione for Innovation and Supplier Expo attendees on May 2, 2018 from 15:10 – 15:40, at Dockside Darling Harbour in Sydney. The conference is sponsored by Complementary Medicines Australia (CMA).

Setria® Performance Blend – a novel combination of L-citrulline and glutathione – may enhance the synthesis, bioavailability, and bio-efficacy of nitric oxide for athletes.* That’s the message Stephen Bailey, Ph.D., gave to attendees at last week’s Nutrition in Athlete Development Summit in Madrid.

Kyowa Hakko USA, a wholly owned subsidiary of Kyowa Hakko Bio Co., Ltd., has completed Generally Regarded as Safe (GRAS) self-affirmation for its Setria® Glutathione ingredient.

Impacts on brain health, muscle mass and strength focus of two presentations at sports nutrition conference.

Kyowa Hakko, manufacturer of fermented amino acids and branded ingredients, today announced the results of a study that evaluated the effects of the antioxidant glutathione (GSH) to brighten skin.

Patent Pending Setria Performance Blend tested to sustain NO Levels for Sports Performance and Cardiovascular Health

Supplement boosts glutathione levels via three distinct pathways

Daily supplement support diminishes signs of aging, promotes healthy skin.

Kyowa is pleased to announce the launch of its premium branded ingredient Setria® Glutathione in the European markets.